The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2019
DOI: 10.22494/cot.v7i1.93
|View full text |Cite
|
Sign up to set email alerts
|

The effects of interleukin-10 and fibroblasts growth factor-2 in mice with toxic cuprizone model of demyelination

Abstract: Cytokines and growth factors exhibit neurotropic, anti-inflammatory and immunomodulatory properties, and therefore can affect the functioning of the nervous system at demyelinating disorders.Purpose. To identify changes in T-lymphocytes, macrophages, oxidative stress and antioxidant defence factors, endocrine thymus function in the brain and behaviour of mice receiving neurotoxin cuprizone and recombinant human proteins: interleukin-10 (rhIL-10) and fibroblast growth factor (rhFGF-2).Materials and methods. 4-6… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(11 citation statements)
references
References 18 publications
(26 reference statements)
1
9
0
Order By: Relevance
“…RhFGF-2, dissolved in saline, was administered to mice intraperitoneally at a dose of 20 μg/kg, starting from the 11 th day of the cuprizone diet, with an interval of 48 hours, a total of 7 injections. This growth factor administration scheme has shown its effectiveness in our previous studies on adult mice with a cuprizone model of demyelination [21].…”
Section: Behavioral Testingmentioning
confidence: 90%
See 4 more Smart Citations
“…RhFGF-2, dissolved in saline, was administered to mice intraperitoneally at a dose of 20 μg/kg, starting from the 11 th day of the cuprizone diet, with an interval of 48 hours, a total of 7 injections. This growth factor administration scheme has shown its effectiveness in our previous studies on adult mice with a cuprizone model of demyelination [21].…”
Section: Behavioral Testingmentioning
confidence: 90%
“…Fibroblast growth factor-2 (FGF-2, basic FGF) alters the migration, proliferation, and differentiation of MMSCs [17,18]. This growth factor also reduces the number of microglial cells and macrophages in the brain, changes the activity of antioxidant enzymes, and improves behavioral responses in animals with experimental models of multiple sclerosis [19][20][21][22]. The production of FGF-2 in MMSCs changes under the influence of melatonin [23].…”
Section: The Effects Of Combined Administration Of Human Umbilical Cord-derived Multipotent Mesenchymal Stromal Cells and Melatonin Or Fimentioning
confidence: 99%
See 3 more Smart Citations